DRRX (DURECT Corp) Rasio Nilai Pasar marang Nilai Buku

Simbol resmi perusahaan durect.com (DRRX)

This daily price chart for DURECT Corporation (DRRX) confirms the influence of factors where the metric stands at 17.49. The business leverages AI systems and robotics to accelerate the bioscreening of formulas. Stability is driven by the development of organ recovery methods and proprietary delivery systems. However, uncertainty regarding test results creates a risk of dependency on FDA decisions, forcing the company to strictly limit its capital expenditure.

DRRX durect.com: Nilai Pasar marang Nilai Buku ing interval 04.07.2022 - 27.09.2025

Rincian metrik keuangan lan pasar DURECT Corporation (DRRX)

- rega lan prakiraan konsensus rega:
Kutipan saham durect.com|DRRX - Prakiraan gabungan firma investasi
- data kapitalisasi pasar:
Nilai pasar DURECT Corp.|DRRX - Nilai Wutuh Bisnis
- data kapitalisasi buku:
Nilai Buku saben Saham DURECT|DRRX - Nilai Akuntansi Perusahaan|Rasio Kapitalisasi Pasar marang Nilai Buku durect.com|DRRX - Total Aset Perusahaan
- data utang lan likuiditas:
Utang marang Ekuitas DURECT Corporation|DRRX - Koefisien utang jangka dawa marang modal|Utang jangka cendhak marang ekuitas durect.com|DRRX - Gunggung utang perusahaan|Utang-utang marang kapitalisasi buku DURECT Corp.|DRRX - Utang jangka dawa perusahaan|Kewajiban jangka cendhak perusahaan DURECT
Analisis wiwitan perusahaan:DURECT Corp - DRRX
Produk asli durect.com

The specifics of DURECT Corporation (DRRX) are driven by colossal R&D expenditures and stringent FDA oversight. This indicator measures the gap between market value and net assets, revealing the extent of the speculative premium. A rising ratio signals inflated market expectations regarding future patents. High values increase the risk of a sharp correction in the event of failed trials. The historical relationship between market cap and book value objectively reflects the current overvaluation of the business.

Pesaing utama

Rasio Kapitalisasi marang Aset Bersih Arrowhead Pharmaceuticals|MIRM (mirumpharma.com) - Rasio Kapitalisasi marang Nilai Buku|Rasio Nilai Pasar marang Nilai Buku dynavax.com DVAX|Kapitalisasi Pasar marang Aset Bersih Arbutus Biopharma Corp|Inventiva Pharma (IVA) - Rasio Kapitalisasi Pasar marang Nilai Buku|Nilai Pasar marang Nilai Buku Gyre Therapeutics Corp. (GYRE)|Rasio Kapitalisasi Pasar marang Nilai Buku ASMB (Assembly Biosciences)|Galectin Therapeutics, Inc. - Rasio Kapitalisasi Pasar marang Nilai Buku|Rasio Nilai Pasar marang Nilai Buku Genfit Corp (GNFT)|ALGS: Nilai Pasar marang Nilai Buku|BIVI (biovieinc.com) - Rasio Nilai Pasar marang Nilai Buku|Galmed Pharmaceuticals Ltd. (GLMD) - Rasio Kapitalisasi marang Aset Bersih|NDRA (ENDRA Life Sciences) - Rasio Kapitalisasi Pasar marang Nilai Buku|Rasio Kapitalisasi Pasar marang Nilai Buku Hepion Pharma (HEPA)